Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Phase I EGFR BATs in Newly Diagnosed Glioblastoma [Phase 1]
A Phase I trial evaluating EGFR BATs in newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study of LP-184 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Lantern Pharma's LP-184 is being studied in a phase 1/2 trial for advanced and metastatic solid tumors, with indications including glioblast…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Response Assessment During MR-guided Radiation Therapy for Glioblastoma
Recruitment is ongoing for a study evaluating response assessment during MR-guided radiation therapy in glioblastoma.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Study of Pamiparib in Newly Diagnosed and rGBM [EARLY_Phase 1]
An early-phase study evaluating pamiparib in newly diagnosed and recurrent glioblastoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial is evaluating superselective intra-arterial cerebral infusion of temsirolimus for high-grade glioma,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma [Phase 1, Phase 2]
Clinical trial update for Verteporfin in recurrent high-grade EGFR-mutated glioblastoma (Phase 1/2) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: CSF Proteomic Characterization of Glioblastomas
A CSF proteomic characterization study in glioblastoma is listed, with the trial currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Ex VIvo DEtermiNed Cancer Therapy
An ongoing clinical trial for an Ex Vivo Determined Cancer Therapy is currently recruiting and spans multiple cancers, including bladder and…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluated the safety, efficacy, and pharmacokinetics of boron neutron capture therapy (BNCT) for recurrent high…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Study of Olutasidenib and Temozolomide in HGG [Phase 2]
Phase 2 study evaluating olutasidenib in combination with temozolomide for high-grade gliomas is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas [Phase 1]
Phase 1 trial of INCB7839 in children with recurrent or progressive high-grade gliomas has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. [NA]
A ClinicalTrials.gov study is currently recruiting to investigate neurovascular uncoupling in patients with brain lesions. The study involve…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma [NA]
The trial is currently recruiting to evaluate carbon ion radiotherapy for high-grade glioma (heavy ion radiotherapy).
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine [Phase 1]
A Phase 1 trial of the Heat Shock Protein Peptide Complex-96 (HSPPC-96) vaccine for glioblastoma and related CNS tumors was terminated. The …
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating NovoTTF-100A (tumor treating fields) combined with bevacizumab in recurrent glioblastoma has completed with results…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma
This completed clinical trial update assesses in situ immune parameters and their prognostic role in the survival of patients with glioblast…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas [NA]
A clinical trial evaluating the efficacy of radiotherapy with SIB-IMRT in combination with temozolomide for adult glioblastoma, currently no…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom [NA]
A completed clinical trial assessed accurate dynamic contrast-enhanced MRI measurements of glioblastoma using a point-of-care portable perfu…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas [Phase 1]
Phase 1 trial evaluating GMCI in combination with nivolumab and radiation therapy for newly diagnosed high-grade gliomas has completed.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
Clinical trial update for AGuIX nanoparticles combined with radiotherapy and concomitant temozolomide in newly diagnosed glioblastoma; a Pha…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF) [NA]
This is an ongoing clinical trial evaluating amplitude-modulated radiofrequency electromagnetic field therapy in combination with radiochemo…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery [Phase 1]
A Phase 1 trial update evaluating the safety and efficacy of a dendritic cell vaccine in combination with temozolomide for newly diagnosed g…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas [EARLY_Phase 1]
Update on an early-phase trial investigating a PTCs-based precision treatment strategy for recurrent high-grade glioma.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas [Phase 1]
Phase 1 safety and efficacy study of a dendritic cell (DC) vaccine for recurrent or progressive high-grade gliomas (WHO grade III and IV) in…